'Moon Shot' Confusion? NIH Chief Provides Clarity
This article was originally published in Scrip
Executive Summary
As with any big new initiatives announced by US presidents during their State of the Union (SOTU) addresses, questions quickly arise about what such proposals mean for Americans and the various sectors of society and commerce: Who's going to be involved, what are the benefits or risks to pursuing the scheme, how much is it going to cost and who's paying for it – with members of Congress almost always jumping on the latter of those in demanding quick answers.
You may also be interested in...
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Clinton's Drug Price Plan: Threat Or Flash In The Political Pan?
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.